Current mental healthcare tools are inadequate, leaving tens of millions of people suffering. Meanwhile, other experimental options fail to understand and address root causes, require burdensome clinical infrastructure, or carry high risk of abuse and side effects.

Our approach is different. With our deep understanding of receptor biology, neuroscience, and translational medicine, we have developed a novel drug discovery platform, which we are using to develop precision neuromodulators to treat CNS diseases at the source—the most logical target.